A detailed history of Pennsylvania Capital Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pennsylvania Capital Management Inc holds 4,043 shares of MRK stock, worth $453,139. This represents 0.19% of its overall portfolio holdings.

Number of Shares
4,043
Previous 3,568 13.31%
Holding current value
$453,139
Previous $470,000 6.38%
% of portfolio
0.19%
Previous 0.19%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$123.8 - $132.96 $58,805 - $63,156
475 Added 13.31%
4,043 $500,000
Q1 2024

Apr 30, 2024

BUY
$113.24 - $131.95 $45,748 - $53,307
404 Added 12.77%
3,568 $470,000
Q4 2023

Feb 08, 2024

SELL
$100.18 - $109.02 $112,502 - $122,429
-1,123 Reduced 26.2%
3,164 $344,000
Q3 2023

Oct 25, 2023

BUY
$102.95 - $114.33 $3,500 - $3,887
34 Added 0.8%
4,287 $441,000
Q2 2023

Jul 18, 2023

BUY
$108.61 - $118.38 $21,287 - $23,202
196 Added 4.83%
4,253 $490,000
Q4 2022

Jan 20, 2023

SELL
$87.44 - $112.11 $78,083 - $100,114
-893 Reduced 18.04%
4,057 $0
Q2 2022

Jul 15, 2022

SELL
$83.49 - $94.64 $8,432 - $9,558
-101 Reduced 2.0%
4,950 $451,000
Q4 2021

Jan 24, 2022

SELL
$72.28 - $90.54 $54,137 - $67,814
-749 Reduced 12.91%
5,051 $387,000
Q3 2021

Nov 05, 2021

SELL
$71.68 - $78.83 $24,442 - $26,881
-341 Reduced 5.55%
5,800 $471,000
Q2 2021

Jul 12, 2021

SELL
$70.31 - $77.77 $4,851 - $5,366
-69 Reduced 1.11%
6,141 $479,000
Q4 2020

Jan 15, 2021

SELL
$71.77 - $79.65 $92,870 - $103,067
-1,294 Reduced 17.24%
6,210 $511,000
Q3 2020

Oct 07, 2020

BUY
$73.18 - $82.95 $337,872 - $382,980
4,617 Added 159.92%
7,504 $610,000
Q2 2020

Jul 17, 2020

SELL
$70.42 - $80.13 $318,439 - $362,347
-4,522 Reduced 61.03%
2,887 $213,000
Q4 2019

Jan 28, 2020

BUY
$77.58 - $87.54 $574,790 - $648,583
7,409 New
7,409 $674,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $284B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Pennsylvania Capital Management Inc Portfolio

Follow Pennsylvania Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pennsylvania Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Pennsylvania Capital Management Inc with notifications on news.